Xylem Pre-tax stock-based compensation cost remained flat by 0.0% to $13.25M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 5.4%, from $14.00M to $13.25M. Over 4 years (FY 2021 to FY 2025), Pre-tax stock-based compensation cost shows an upward trend with a 12.6% CAGR.
other_allocated_share_based_compensation_expense| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $33.00M | $37.00M | $60.00M | $56.00M | $53.00M |
| YoY Change | — | +12.1% | +62.2% | -6.7% | -5.4% |